BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1811743)

  • 1. [The sterilization of ophthalmic solutions].
    Pănescu C
    Oftalmologia; 1991; 35(1):69-74. PubMed ID: 1811743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterility testing of ophthalmic ointments using isopropyl myristate.
    Robertson JH
    Bull Parenter Drug Assoc; 1974; 28(6):288-94. PubMed ID: 4455325
    [No Abstract]   [Full Text] [Related]  

  • 3. [Compounding of ophthalmic drugs in the pharmacy. Special care must be taken!].
    Daniels R
    Pharm Unserer Zeit; 2010 Jul; 39(4):306-11. PubMed ID: 20589805
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterility of non-preservative eye drops.
    Prabhasawat P; Chotikavanich S; Leelaporn A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preservative agents and parameters determining their effectiveness].
    Jaminet F
    Farmaco Prat; 1970 Aug; 25(8):457-500. PubMed ID: 4990130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotic stability in magistral collyria].
    Tihărău A; Voiculescu E; Vancea S; Teodorescu A; Cherecheş S
    Oftalmologia; 1990; 34(2):97-104. PubMed ID: 2101048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of the stability of dioxopromethazine in aqueous solutions and ophthalmic instillation].
    Capkova Z; Hudecová T; Hatrík S; Havránek E; Vitková Z
    Ceska Slov Farm; 2004 Jul; 53(4):187-91. PubMed ID: 15369230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibility of sterilizing eyedrops by a bacterial filtration method].
    Danilenko AA; Sokolova IP; Sipinskaia OF; Kurilenko AV
    Farmatsiia; 1978; 27(5):50-2. PubMed ID: 700186
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ON THE PREPARATION OF OPHTHALMIC SOLUTIONS: ANTIMICROBIAL APPARATUS].
    DUBAN G
    Boll Chim Farm; 1964 Dec; 103():849-66. PubMed ID: 14261694
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
    Kodym A; Marcinkowski A; Kukuła H
    Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of the technology of the substance of davikol and standardization].
    Bakuridze A; Shengelia D; Kurdiani N; Mikaia G; Karanadze N
    Georgian Med News; 2008 Jan; (154):43-7. PubMed ID: 18323593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of contaminating bacteria in over-the-counter artificial tears.
    Harris MG; Gee A; Kusumoto R; Lee H
    J Am Optom Assoc; 1996 Nov; 67(11):676-80. PubMed ID: 8979661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physical and chemical stability of fortified ophtalmic ready-to-use solutions: review of literature].
    Sourdeau P; Evrard JM; Remy G; Hecq JD
    Ann Pharm Fr; 2012 Mar; 70(2):104-12. PubMed ID: 22500962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and sterility of multidose ophthalmic medications.
    Tamer HR; Sweet BV; Ross MB
    Am J Hosp Pharm; 1994 Feb; 51(4):500-2. PubMed ID: 8017416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriologic evaluation of ophthalmic methylcellulose preparations prepared at the hospital].
    Irkeç M; Yuluğ A
    Mikrobiyol Bul; 1988; 22(3):235-7. PubMed ID: 3252115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of formulation of hipromellose eye drops (artificial tears)].
    Inkeniene AM; Klimas R; Briedis V; Maciulevicius J
    Medicina (Kaunas); 2003; 39(1):77-82. PubMed ID: 12576769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pharmacist's view on collyria (author's transl)].
    Veselý V
    Cesk Oftalmol; 1981 Sep; 37(5):365-71. PubMed ID: 7317971
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriological control of collyria.
    Papavassiliou J; Albalas B; Zouroudis N; Chitiroglou-Lada K; Siouti M
    Pharm Acta Helv; 1977; 52(12):293-5. PubMed ID: 615315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.